Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

E. Van Cutsem, C. Boni, J. Tabernero, B. Massuti, G. Middleton, F. Dane, P. Reichardt, F.L. Pimentel, A. Cohn, P. Follana, M. Clemens, A. Zaniboni, V. Moiseyenko, M. Harrison, D.A. Richards, H. Prenen, S. Pernot, E. Ecstein-Fraisse, S. Hitier, P. Rougier Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium Department of Oncology, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy Department of Medical Oncology, Vall d’Hebron University Hospital and Institute of Oncology (VHIO),